TipRanks
Go Ultimate55% OFF

Implanet SA (IM11) Stock Price & Analysis

IM11 Stock Chart & Stats

€0.14€0.00(0.70%)
At close: 5:30 PM GMT+1
€0.15€0.175€0.2€0.22520 Apr26 Jun29 Jun
Day’s Range
EUR 0.14 - EUR 0.14
52-Week Range
EUR 0.14 - EUR 0.27
Previous Close
EUR 0.14
Volume
0
Average Volume (3M)
0
Market Cap
EUR 21.40M
Enterprise Value
EUR 28.61M
Total Cash (Recent Filing)
EUR 1.01M
Total Debt (Recent Filing)
EUR 5.46M
Price to Earnings (P/E)
―
Beta
-0.31
Next Earnings
Mar 09, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

The strong rebound in revenue indicates improving commercial traction for Implanet’s orthopedic and spine products. Sustained top-line expansion can broaden the installed customer base, support operating leverage, and provide a foundation for future earnings improvement if growth continues.

Gross Margin Expansion

The material gross-margin improvement suggests a more favorable product mix, pricing profile, or sales economics. If maintained, higher gross profit per sale should improve the company’s ability to fund commercial activity and absorb fixed costs as revenue scales.

Improving Operating Cash Flow

Although operating cash flow remains negative, the sharp year-over-year improvement shows reduced cash consumption from operations. Continued progress toward break-even could lessen funding pressure and increase financial flexibility as the company’s revenue base expands.

Bears Say

Persistent Losses

Persistent operating and net losses show that revenue growth and better gross margins have not yet translated into a sustainable earnings model. Until profitability improves, Implanet may have less capacity to reinvest, absorb setbacks, or build equity internally.

High Leverage

The very thin equity cushion leaves the company financially sensitive to further losses and execution shortfalls. High leverage can constrain capital allocation, increase dependence on financing, and reduce resilience while the business is still working toward profitability.

Negative Free Cash Flow

Ongoing negative free cash flow means the company is not yet funding its investment and operating needs through internally generated cash. Continued cash deficits can require external funding and may limit the pace or reliability of strategic growth initiatives.

IM11 FAQ

What was Implanet SA’s price range in the past 12 months?
Implanet SA lowest stock price was €0.14 and its highest was €0.27 in the past 12 months.
What is Implanet SA’s market cap?
Implanet SA’s market cap is €21.40M.
When is Implanet SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Implanet SA’s earnings last quarter?
Implanet SA released its earnings results on Sep 15, 2026. The company reported -€0.015 earnings per share for the quarter.
Is Implanet SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Implanet SA pay dividends?
Implanet SA does not currently pay dividends.
What is Implanet SA’s EPS estimate?
Implanet SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Implanet SA have?
Implanet SA has 143,818,970 shares outstanding.
What happened to Implanet SA’s price movement after its last earnings report?
Implanet SA reported an EPS of -€0.015 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Implanet SA?
Currently, no hedge funds are holding shares in DE:IM11
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology